Ilika finds alignment as battery sector expectations evolve

Ilika Plc

Ilika’s latest appearance at the Battery Show North America revealed that the company’s position is becoming more relevant as the battery sector moves into a new phase, one defined less by volume and more by differentiation.

In a year where pricing pressure has hammered conventional lithium-ion suppliers, Ilika’s oxide solid-state chemistry stood out not for its visibility but for its timing. The industry is recalibrating. Battery cell costs, especially in China, have dropped sharply. LFP prices alone fell by up to 20% in 2024, setting a bar that Western producers are unlikely to match without compromising margins. For Ilika, that shift makes its long-standing focus on performance and safety a clear strategic advantage. What became obvious at the show was that leading OEMs are no longer looking just for cheaper batteries. They are looking for safer, more compact, longer-lasting solutions, attributes Ilika has prioritised from the start.

The company noted strong interest in its Stereax technology, which targets applications where footprint and safety are critical. That’s no longer a niche conversation. It’s now central to discussions about how to replace incumbent lithium-ion designs without triggering a new set of risks or costs. Meanwhile, the emergence of LMR (lithium manganese rich) cathodes and nickel-light formulations shows that even major cell developers are searching for ways to move beyond legacy materials, and are increasingly open to external innovation to do it.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Search